Showing results (1841-1850 of 1,853) with videos related to
Sort By:
Pageof 186
Journal of Managed Care & Specialty Pharmacy|June 26, 2020
Development and Implementation of Clinical Outcome Measures for Automated Collection Within Specialty Pharmacy PracticeKatherine Patel, Yee-Ling Chim, Jonathan Grant, et al.Journal of Managed Care & Specialty Pharmacy|May 28, 2016
Ability and Use of Comparative Effectiveness Research by P&T Committee Members and Support Staff: A 1-Year Follow-upJill Augustine, Terri L Warholak, Lisa E Hines, et al.Journal of Managed Care & Specialty Pharmacy|July 27, 2026
Economic value of ribociclib in early breast cancer in the United StatesAdam Brufsky, Sara M Tolaney, Vijayakrishna K Gadi, et al.Journal of Managed Care & Specialty Pharmacy|July 27, 2026
Clinical harm from failure to deploy personalized medicine for patients with metastatic non-small cell lung cancerKristen Migliaccio-Walle, Scott J Spencer, David L Veenstra, et al.Journal of Managed Care & Specialty Pharmacy|July 27, 2026
Evaluating the feasibility of health care databases for assessing the safety of switching between originator biologics and biosimilarsAaron B Mendelsohn, Terese A DeFor, Djeneba Audrey Djibo, et al.Journal of Managed Care & Specialty Pharmacy|August 25, 2026
Who is responsible? A risk-stratified framework for pharmacist accountability in artificial intelligence-assisted managed careEmine Gülce Byers, Chalissa Dibya IranishaJournal of Managed Care & Specialty Pharmacy|August 25, 2026
A pharmacist-overseen, artificial intelligence-enabled model for provider-side prior authorization: From burden to opportunity (PAVE-1)Jorge A Valedon Navarro, Rachel ReiseJournal of Managed Care & Specialty Pharmacy|August 18, 2026
Economic burden of immune-mediated and psychiatric comorbidities in patients with newly diagnosed vitiligoDavid Rosmarin, Ahmed M Soliman, Kent A Hanson, et al.Journal of Managed Care & Specialty Pharmacy|September 29, 2026
Return on investment of SGLT2 inhibitors and GLP-1 receptor agonists: Implications of real-world use for managed careHannah Rapp, David Marr, Ashley Modany, et al.Journal of Managed Care & Specialty Pharmacy|September 29, 2026
Payers should cover COVID-19 vaccines for all ages and risk groups with no patient cost sharingRandy C Hatton, Laura E HappePageof 186